DOI: 10.1093/geronj/38.2.137
Keywords: GLP-1 receptor agonists, neuroprotection, neuroinflammation, Alzheimers disease, Parkinsons disease Introduction Neurological disorders are a leading cause of death and disability worldwide and place a huge burden on patients, families, and healthcare systems
In August 2025, the FDA also approved Wegovy for the treatment of noncirrhotic MASH with moderate to advanced liver fibrosis 8
Insurance companies have also tightened requirements, mandating everything from doctor's notes to detailed weight histories to strict BMI thresholds
Here are the steps you can expect: Consultation Evaluation Treatment plan Prescription Followup After your consultation, they will ask questions about your overall health history, medical history for type 2 diabetes , and weight-loss journey if you struggle with obesity
Prioritize your water intake (between 11-15 cups is ideal for adults) to keep your body functioning at its best